Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.
about
The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 MelanomaEffect of BMAP-28 on human thyroid cancer TT cells is mediated by inducing apoptosis.A tetrameric peptide derived from bovine lactoferricin as a potential therapeutic tool for oral squamous cell carcinoma: A preclinical model.The oncolytic peptide LTX-315 triggers necrotic cell death.LTX-315, CAPtivating immunity with necrosis.The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade.The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment.Antimelanoma effect of Salmonella Typhimurium integration host factor mutant in murine model.Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma.Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model.In vitro and in vivo cytotoxic activity of human lactoferricin derived antitumor peptide R-DIM-P-LF11-334 on human malignant melanoma.LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent.Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways.Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.Effects of talactoferrin alpha on lung adenoma prevention in A/J mice June 2, 2016.The oncolytic compound LTX-401 targets the Golgi apparatus.Unraveling the bioactivity of anticancer peptides as deduced from machine learningOncolysis with DTT-205 and DTT-304 generates immunological memory in cured animalsThe anticancer peptide RT53 induces immunogenic cell death
P2860
Q35924903-82ED14F8-0CF2-4110-B75E-8A4E4BE8A1F5Q36085953-85408B6F-A84C-4362-8619-13AAAFE4E4BEQ36328218-CB56AF61-08EB-4A59-AB03-C1A767980342Q36780793-DA7EE9B7-AC3E-437A-A9BD-178292D03EE1Q36957051-92EA251C-D38A-433E-A49E-85F9848FE4CAQ37181696-C222132C-9C18-43F8-9F2E-8F767E77E47AQ38260167-FCFF30AF-A1EB-4ADE-8DF0-2217510CD257Q38685556-0F00EE4B-5480-4362-B5EE-2067AEFDB84AQ38850160-97C82987-6E9B-40DF-BE39-64991D61FCD4Q39250554-98666321-B21C-43E4-A3A2-2225C3FB0BDCQ39332189-4D3A16B5-B8C1-43A8-9E66-EFC7F6B77C3AQ41338711-B0C4C83B-2F5B-446E-813C-4B38B024FA25Q42700874-B8ABAA11-B0E1-4F41-BD16-91E7B1108F96Q42745372-645682D1-56FF-4199-9268-E2022F3DBAA6Q46014528-C3818F1E-D81A-45BE-AD12-2753BF7132F5Q47135720-76916CB2-7850-4C57-BE9B-A76EDF894D98Q52720148-71A49AEB-6B40-4A36-86C2-B8A48786677EQ53035836-3E77EDC0-64BF-45A9-8819-325A582F91F6Q57174709-1FBFD723-EDBF-43EF-88EB-CC7D37261C0FQ57796314-3D22CF31-AEDD-4DC7-A054-8A6520B5A8E0Q58799814-519F7484-B7A3-4FE1-B99B-2FCAD6ECDEA0
P2860
Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Complete regression and system ...... after treatment with LTX-315.
@ast
Complete regression and system ...... after treatment with LTX-315.
@en
type
label
Complete regression and system ...... after treatment with LTX-315.
@ast
Complete regression and system ...... after treatment with LTX-315.
@en
prefLabel
Complete regression and system ...... after treatment with LTX-315.
@ast
Complete regression and system ...... after treatment with LTX-315.
@en
P2093
P2860
P1476
Complete regression and system ...... after treatment with LTX-315.
@en
P2093
Baldur Sveinbjørnsson
Chandra Sekhar Ravuri
Gerd Berge
Ketil André Camilio
Oystein Rekdal
P2860
P2888
P304
P356
10.1007/S00262-014-1540-0
P577
2014-03-28T00:00:00Z
P5875
P6179
1010355980